10 Firms With Massive Gains; 5 at Record Highs

Page 9 of 9

1. Revolution Medicines, Inc. (NASDAQ:RVMD)

Revolution Medicines soared to a new all-time high on Wednesday, as investors took path from a report from The Wall Street Journal that it was set to be acquired by AbbVie that could value the former $20 billion, albeit the latter later in the day debunked the report.

At intra-day trading, Revolution Medicines, Inc. (NASDAQ:RVMD) climbed to its highest price of $105 before paring gains to finish the day just up by 28.63 percent at $102.71 apiece. Wednesday’s trading was a significant jump from the near $80 level the day prior.

According to WSJ, AbbVie was in advanced talks to acquire Revolution Medicines, Inc. (NASDAQ:RVMD), which would have been the first mega deal blowout for the year. Trading in its shares also halted twice due to price volatility.

However, Reuters reported, quoting AbbVie as saying that it was “not in discussions with Revolution Medicines.”

Founded in 2014, Revolution Medicines, Inc. (NASDAQ:RVMD) is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.

In an announcement on Monday, the company said that its Chairman and CEO Mark Goldsmith would participate in the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12.

Investors will be closely watching out for cues about its outlook for 2026, as well as updates about its pipelines.

While we acknowledge the potential of RVMD to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than RVMD and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.

Page 9 of 9